The question in this case was about the clarification of the “interested person” mentioned in section 60(1) of the Patent Act. Apotex Inc. (“Apotex”) had brought an action under section 60(1) of the Patent Act seeking a declaration that Patent No. 2, 163,446 owned by Pfizer Ireland Pharmaceuticals (“Pfizer”) was invalid and that Apotex’s pills were non-infringing.
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to Canadian Intellectual Property Blog: Apotex Inc. v. Pfizer Ireland Pharmaceuticals, 2012 FC 1301.
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account
account